Thrombophilic molecular markers in young patients (<40 years) with coronary artery disease.

Simple item page
dc.contributor.authorSherpa, Mingma
dc.contributor.authorSharma, Satendra
dc.contributor.authorAvasthi, Rajnish
dc.date.accessioned2012-10-18T05:30:30Z
dc.date.available2012-10-18T05:30:30Z
dc.date.issued2012-07
dc.description.abstractBackground: There has been an alarming rise in the incidence of coronary artery disease (CAD) in India especially involving the age group of less than 45 years. In recent past, various studies focused on hemostatic aspects of CAD, but could not determine the significance of thrombophilic molecular marker in combination. The study was undertaken to investigate the association of thrombophilia related molecular markers in young patients with CAD. Materials and Methods: Thirty diagnosed patients with CAD of either sex under 40 years were included. Thirty healthy age and sex matched control subjects without evidence of CAD formed the control group. Detailed history and clinical examination findings were recorded. In addition to routine investigations, polymerase chain reaction (PCR) based molecular analysis for Factor V Leiden (FVL), methyltetrahydrofolate reductase (MTHFR) gene, tumor necrosis factor receptor 2 (TNFR2) gene, and prothrombin gene mutation were carried out. Results: The mean age (± SD) was 36.86 ± 3.90 years in the patients. Smoking was the most prevalent risk factor. FVL, MTHFR and TNFR2 gene mutation were seen in nine (30%) patient. Three patients had presence of more than one mutation. FVL, MTHFR and TNFR2 gene mutation was found in 4 (13.3%), 3 (10%), and 5 (16.6%) patients respectively. Prothrombin gene mutation was not seen in any of the subjects. There was no significant difference in lipid profile, fibrinogen levels and CRP among the patients with mutation and patients without mutation. Conclusion: Almost one-third of the cases were positive for the various mutations in the study and the presence of at-least one or the other risk factor adds on to the risk of future thrombosis. There is a need to demonstrate or document these mutations in a larger group further based upon ethnicity and geographic distribution.en_US
dc.identifier.citationSherpa Mingma, Sharma Satendra, Avasthi Rajnish. Thrombophilic molecular markers in young patients (<40 years) with coronary artery disease. Indian Journal of Pathology & Microbiology. 2012 Jul-Sept 55(3): 343-346.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/142264
dc.language.isoenen_US
dc.source.urihttps://www.ijpmonline.org/article.asp?issn=0377-4929;year=2012;volume=55;issue=3;spage=343;epage=346;aulast=Sherpaen_US
dc.subjectCoronary artery diseaseen_US
dc.subjectFactor V Leidenen_US
dc.subjectmethyltetrahydrofolate reductaseen_US
dc.subjectprothrombinen_US
dc.subjectthrombophiliaen_US
dc.subjecttumor necrosis factor receptor 2en_US
dc.titleThrombophilic molecular markers in young patients (<40 years) with coronary artery disease.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijpm2012v55n3p343.pdf
Size:
617.37 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Pathology & Microbiology